How AI Can Be Used In Alzheimer's Clinical Research
Source: Clinical Leader
IGC Pharma is in the process of running a Phase 2B trial on Alzheimer's, looking at the neuropsychiatric symptoms associated with the disease. But as company CEO, Ram Mukunda, explains, there are thousands of datapoints that need to be analyzed for each patient, which is where AI comes in.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
This website uses cookies to ensure you get the best experience on our website. Learn more